3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
2
Lymphoid
2
Thoracic
1
Other hematologic neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
88
fludarabine phosphate
77
Busulfan
56
Tacrolimus
54
Mycophenolic Acid
54
Antilymphocyte Serum
48
Peripheral Blood Stem Cell Transplantation
46
Filgrastim
42
Melphalan
41
Cyclosporine
39
Whole-Body Irradiation
38
fludarabine
36
Radiotherapy
32
Methotrexate
28
Cord Blood Stem Cell Transplantation
25
Methylprednisolone
24
Alemtuzumab
17
Etoposide
16
Thiotepa
15
Rituximab
14
Cytarabine
14
thymoglobulin
13
Granulocyte Colony-Stimulating Factor
12
Stem Cell Transplantation
10
sargramostim
9
Sirolimus
9
Flow Cytometry
9
Psychiatric Rehabilitation
8
Prednisone
7
Mesna
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Tinzaparin
×
Myeloid
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled